-
Concept Medical Group recognized among India’s top 30 Mid-Size Best Workplaces in manufacturing 2026
02 Feb 2026 17:45 GMT
… patented, nanocarrier-based drug-delivery platforms. Headquartered … s first commercially available sirolimus-coated balloon (SCB) … Medical';s evidence base spans 45+ clinical trials involving … approval, U.S. FDA Breakthrough Device Designation, and …
-
Business News | Concept Medical Group Recognized Among India's Top 30 Mid-Size Best Workplaces in Manufacturing 2026
02 Feb 2026 15:51 GMT
… patented, nanocarrier-based drug-delivery platforms. Headquartered … s first commercially available sirolimus-coated balloon (SCB) … Medical';s evidence base spans 45+ clinical trials involving … approval, U.S. FDA Breakthrough Device Designation, and …
-
Global Drug Device Combination Products Market to Reach USD 379.17 Billion by 2030 | MarketsandMarkets™
30 Jan 2026 14:30 GMT
… Drug-device combination products must comply with both pharmaceutical and medical …
Regulators, including the FDA, have intensified oversight … increasingly prefer home-based treatment to save time, … and Ultimaster Tansei sirolimus-eluting coronary stents …
-
Studies confirm that drug-coated balloons can replace stents-even in larger coronary arteries
27 Jan 2026 18:18 GMT
… drug-coated balloon (DCB) has become an internationally recognized treatment … University Medical Center in Homburg. ‘The advantage of drug-coated … of the international clinical trials on DCBs that are … DeNovo trial comparing a strategy of PCI with a sirolimus- …
-
Biodexa Announces Exclusive License of Otsuka’s OPB-171775, a potent Phase 1 ready Molecular Glue for GIST
04 Feb 2026 13:30 GMT
… and incentives to support drug development. Licensing and … com
About Biodexa Pharmaceuticals PLC Biodexa Pharmaceuticals PLC (listed on … for the treatment of diseases with unmet medical needs. The … rapamycin, also known as sirolimus. Rapamycin is an mTOR …
-
Concept Medical Announces First Patient Enrollment in STARS DAPT Randomized Clinical Trial Evaluating Abluminus NP Polymer-Free DES
22 Jan 2026 13:41 GMT
… ) randomized controlled trial. This trial marks a significant … free drug eluting stent (DES) for the treatment … of balloon) with sirolimus drug coated on the … HEALTH TECHNOLOGY CLINICAL TRIALS PHARMACEUTICAL BIOTECHNOLOGY
SOURCE: Concept Medical Inc.
Copyright …
-
Immunosuppressants Kits Market to Reach USD 2,920.7 million by 2036 on Rising Demand for Transplant Drug Monitoring
16 Jan 2026 12:25 GMT
… blood concentrations of drugs such as tacrolimus, cyclosporine, sirolimus, everolimus, and … accuracy.
Applications Concentrated in Transplant Medicine
By clinical application, kidney … /MS assays. Academic medical centers and private or specialty …
-
Lexeo Therapeutics Announces Positive Interim Phase I/II Data for LX2020 for the Treatment of PKP2-Associated Arrhythmogenic Cardiomyopathy
12 Jan 2026 12:00 GMT
… genetic medicine company dedicated to pioneering novel treatments for … and sirolimus in two participants per the trial protocol. … Orphan Drug and Fast Track designations by the FDA. … preclinical studies, clinical trials and research and development …
-
Liver Transplantation Market to Reach US$ 3,010.1 Mn by 2032 at 6.8% CAGR | Persistence Market Research
04 Feb 2026 06:43 GMT
… Immunological Challenges
Despite medical advancements, organ … Solutions
Immunosuppressive Drugs
Others
By Treatment Type: … -Rejection Treatment
Cyclosporine
Tacrolimus
Sirolimus Prednisone … , Conatus Pharmaceuticals Inc., Digna Biotech, and RedHill …
-
Solaris Endovascular Announces Completion of Enrollment in DEScover Trial
08 Jan 2026 21:15 GMT
… announced that the DEScover Clinical Trial has successfully completed enrollment.
DEScover … Solaris DE sirolimus-eluting, electrospun PTFE covered stent for the treatment of … local drug delivery,” said Marco Costa, MD, PhD, Chief Scientific & Medical …